IMPERA MEDICINES Trademark
Trademark Overview
On Wednesday, March 20, 2024, a trademark application was filed for IMPERA MEDICINES with the United States Patent and Trademark Office. The USPTO has given the IMPERA MEDICINES trademark a serial number of 98459161. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, November 14, 2024. This trademark is owned by Impera Medicines, LP. The IMPERA MEDICINES trademark is filed in the Advertising, Business and Retail Services, Pharmaceutical Products, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:
medicinal preparations for the treatment of infectious diseases and for use in oncology; biological preparations for the treatment of cancer; anti-cancer preparations; medicinal preparations for the treatment of cardiometabolic diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cardiometabolic diseases; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, cardiometabolic, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
investment consultancy for biotechnology companies; investment management for biotechnology companies; financial services, namely, investment management and advisory services in the field of biotechnology; intellectual property venture fund management services in the field of biotechnology
Business consultancy in the field of biotechnology; professional business consulting for biotechnology companies; business consulting, business management and providing information in the biotechnology business field; business services, namely, assisting the owners of intellectual property and intangible assets in the field of biotechnology in finding investors
research and development services in the fields of immunology and oncology; research and development services in the field of cardiometabolic diseases; medical research in the field of oncology; medical research in the field of immunology; medical research in the field of cardiometabolic diseases; research, development, engineering and testing services in the field of pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, cardiometabolic, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
General Information
| Serial Number | 98459161 |
| Word Mark | IMPERA MEDICINES |
| Filing Date | Wednesday, March 20, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, November 14, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 3, 2024 |
Trademark Statements
| Goods and Services | medicinal preparations for the treatment of infectious diseases and for use in oncology; biological preparations for the treatment of cancer; anti-cancer preparations; medicinal preparations for the treatment of cardiometabolic diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cardiometabolic diseases; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, cardiometabolic, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders |
| Goods and Services | investment consultancy for biotechnology companies; investment management for biotechnology companies; financial services, namely, investment management and advisory services in the field of biotechnology; intellectual property venture fund management services in the field of biotechnology |
| Goods and Services | Business consultancy in the field of biotechnology; professional business consulting for biotechnology companies; business consulting, business management and providing information in the biotechnology business field; business services, namely, assisting the owners of intellectual property and intangible assets in the field of biotechnology in finding investors |
| NOT AVAILABLE | "MEDICINES" |
| Goods and Services | research and development services in the fields of immunology and oncology; research and development services in the field of cardiometabolic diseases; medical research in the field of oncology; medical research in the field of immunology; medical research in the field of cardiometabolic diseases; research, development, engineering and testing services in the field of pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, cardiometabolic, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 20, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 20, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 20, 2024 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 20, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Impera Medicines, LP |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 13 - Limited Partnership |
| Address | San Diego, CA 92121 |
Trademark Events
| Event Date | Event Description |
| Wednesday, March 20, 2024 | NEW APPLICATION ENTERED |
| Friday, August 16, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, September 28, 2024 | ASSIGNED TO EXAMINER |
| Friday, October 4, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, October 4, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Friday, October 4, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, October 4, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Monday, November 11, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
